Optimizing Early Ophthalmology Clinical Trials: Home OCT and Modeling Can Reduce Sample Size by 20% to 40%
By reducing sample size requirements while maintaining statistical power, this approach can streamline clinical trials, expediting the development of new retinal therapies and improving patient access to treatment.
Authors
- Bernhard Steiert (ORCID: https://orcid.org/0000-0002-1398-1624)
- Jacques Hermes (ORCID: https://orcid.org/0000-0003-3608-5969)
Institutions
- Roche (Switzerland) (CH)
- University of Freiburg (DE)
Publication Details
- Journal
- Translational Vision Science & Technology
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1167/tvst.14.9.2
- Citations
- 1
- Primary Topic
- Retinal Imaging and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 1.36